Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.
about
FAT10 plays a role in the regulation of chromosomal stabilityCancer, inflammation and the AT1 and AT2 receptorsInnate immunity and inflammation in ageing: a key for understanding age-related diseasesRole of innate immunity in the development of hepatocellular carcinomaLive imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growthNF-κB, JNK, and TLR Signaling Pathways in HepatocarcinogenesisBioactive Nutrients and Nutrigenomics in Age-Related Diseases.Current and future technology for minimally invasive ablation of renal cell carcinomaInvolvement of tumor necrosis factor-alpha in the upregulation of CXCR4 expression in gastric cancer induced by Helicobacter pylori.Predicting combinatorial binding of transcription factors to regulatory elements in the human genome by association rule miningTargeting TNF-alpha for cancer therapy.Proteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis.Doxorubicin-mediated apoptosis in glioma cells requires NFAT3.Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-reviewTNF-α -308 A allele is associated with an increased risk of distant metastasis in rectal cancer patients from Southwestern China.Growth of breast cancer recurrences assessed by consecutive MRIComparison of caspase-3 activation in tumor cells upon treatment of chemotherapeutic drugs using capillary electrophoresis.The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro - evaluation towards understanding breast cancer cell bone metastasis.Effects of ulinastatin and docataxel on breast tumor growth and expression of IL-6, IL-8, and TNF-α.Chronic Inflammation: Accelerator of Biological Aging.FAT10, a gene up-regulated in various cancers, is cell-cycle regulated.Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial.Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells.MUC1 protein expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with nuclear factor-κB p65 and binding to cytokine promoters: importance of extracellular domain.Improved cryosurgery by use of thermophysical and inflammatory adjuvants.Tumour Necrosis Factor-α Gene Polymorphism Is Associated with Metastasis in Patients with Triple Negative Breast CancerRenal cell carcinoma with secondary hemophagocytic syndrome: A case report.TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway.IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity.P2X(7) receptor: Death or life?The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence.Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors.Associations of circulating inflammatory biomarkers with risk factors for colorectal cancer in colorectal adenoma patientsInhibition of tumor growth by NF-kappaB inhibitors.The tumor microenvironment: key to early detection.CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction.Regulation of ERalpha-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: implications for breast cancer cell survival.Tumor necrosis factor-α (TNF-α)-308G/A promoter polymorphism in colorectal cancer in ethnic Kashmiri population - A case control study in a detailed perspective.Inflammation and cancer: role of nuclear factor-kappaB activation.
P2860
Q24305422-E41386B1-E00C-4AE2-861E-FC33382A3102Q24806378-28F6A410-F3CB-4E25-8FA8-A3804615CA26Q24814846-D74219C1-0E7D-4375-9371-F1F3DCC3369BQ27024780-F9F19D98-4A93-437D-9879-236005809537Q27300769-FDB3038E-4D6F-405A-A28F-488C844DA75FQ28384956-96D98706-57AC-4180-8828-F580A9F9C5B8Q30239072-E1FE5609-0843-4FC2-8F6D-90461372FBE7Q30478546-2E59A887-8FC1-4236-8724-97BA111919C3Q30986955-A436E545-542E-4E16-AB49-5FF1AAE49BA4Q33305716-BAD576CF-1A1B-47D2-8BF5-2036E6CCFA00Q33513307-5A22D6C4-D529-4C15-BCEB-31094020E80FQ33547651-25EB753C-78E5-42DC-9427-C3F5CE18F527Q33604236-DA1D6232-D83F-49BF-81C1-69C9E709720EQ33731768-21B17E72-D812-43B5-A995-78C891786D5CQ33757402-611E0347-6C2F-4D57-A3E8-84C832EC785AQ33884067-458B5770-08A0-4268-9D32-54CE910A60C8Q34243306-7A163D88-CA5A-41E2-9D85-2DC89881B821Q34365807-B84B0F2B-D230-4DC0-BC5D-70D0DD85B2A3Q34633205-6AFAB7A0-3E2A-4554-BFC9-8F0665DD8836Q34680346-D0ABDF27-3D63-4BDA-A982-0D7733D8F5ECQ35039785-3E680089-20A6-44C0-92CE-76F8A53E3811Q35221813-F89EA84B-0C0F-44F1-BD8F-1D5406A175DAQ35281372-57253894-EE61-447B-8EEA-D83AC77F5347Q35551987-EB2154B7-A69B-4072-8651-89BBCDFA83BFQ35605048-553C1F89-2064-4C8A-8F2D-B81BCEE5BD97Q35731918-1D0CB6A7-27EF-42C3-A1D2-C65963411F5DQ35844698-0ED16961-8308-447B-AE06-BB053324E089Q35894645-8E16CD25-6EF6-4513-BA30-766011DD9181Q35963258-F0C1E27D-4C1B-4621-BFA6-CA355AB99FB2Q36005345-82802E6E-E979-42CB-8B5E-4BD4D1E4AEA1Q36173773-1BFF3B06-0884-4008-B305-853B3008762DQ36249221-5BC012AA-7EBA-4A7D-8980-58B24F91FCEBQ36345961-57CCF463-93A9-4152-8306-A0EC3E5EBC0DQ36401610-4FC9D7E1-6737-4F78-A31C-D750F0C9E3AEQ36573962-0E680F7D-BC36-4A7C-87C7-E908A721A5A4Q36627750-4B2A869C-D617-45A8-AC7C-660EDAF9CC7BQ36711861-CA089154-E690-4C59-9017-8DEDF097C5CDQ36731304-DD22977D-0FAF-453E-8BF9-9AB717719CDDQ37005360-48948B68-F6F6-4BF4-A7A1-27B828878BD7Q37092305-49C9C855-5406-4FD8-B472-4FB1DE86BAE0
P2860
Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.
@ast
Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.
@en
type
label
Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.
@ast
Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.
@en
prefLabel
Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.
@ast
Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.
@en
P1433
P1476
Tumour necrosis factor alpha: a potential target for the therapy of solid tumours
@en
P2093
Peter W Szlosarek
P304
P356
10.1016/S1470-2045(03)01196-3
P577
2003-09-01T00:00:00Z